Study Exploring the Supportive Effect of Acarbose in Weight Management
NCT05934110
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
320
Enrollment
INDUSTRY
Sponsor class
Conditions
Overweight or Obesity
Interventions
DRUG:
EMP16-120/40
DRUG:
MR orlistat 120 mg
DRUG:
Conventional orlistat 120 mg,
DRUG:
EMP16-60/20
DRUG:
Placebo
Sponsor
Empros Pharma AB
Collaborators
[object Object]